health economics
Last updated on
Dr Adam Wagner is a Research Fellow in the Health Economics theme, based at the Health Economics Group at the University of East Anglia (UEA). He originally trained as a Statistician (PhD from the University of Strathclyde) and has also completed an MSc in Health Economics at UEA (funded by the CLAHRC EoE). Adam provides health economic and statistical support for the CLAHRC East of England. Since 2010, he has worked in health services research, with a particular focus on health and social care services supporting women and men with learning (intellectual) disabilities and acquired brain injuries. While continuing this…
Chris Skedgel is Senior Lecturer in Applied Health Economics in the Health Economics Group at the Norwich Medical School, University of East Anglia. His primary research interest is around the role of public preferences over the allocation of limited resources in promoting societal value and distributive justice in healthcare. This includes the development of stated preference methods for eliciting valid and reliable societal preference weights as well as processes for incorporating public preferences into priority-setting. He also conducts economic evaluations to consider the 'value-for-money' of new interventions and has worked in disease areas including cancer, haematology, rheumatology, multiple sclerosis, cardiovascular…
After graduating with degrees in Economics and Health Economics at the Universities of Southampton and York David worked as a health economist a number of Universities. A key component of David’s academic career has been the design, implementation and analysis of economic evaluations alongside clinical studies, particularly randomized controlled trials. He has been involved in numerous trials as the health economist. David has also been involved with a number of health economic models as well as NICE technology appraisals. A feature of his research career has been involvement in multi-disciplinary research. He has collaborated with a number of clinical and…
Professor Garry Barton has a chair in Health Economics and is a member of the Health Economics Group, Norwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia and his main area of expertise is in the application and development of the methods of economic evaluation. Methodological work which Professor Barton has undertaken includes the comparison of two measures of utility (the EQ-5D and SF-6D) which can be used to measure the benefits of interventions, where the practicality, construct validity, and responsiveness of these two measures were assessed. As a health economist, Garry is a co-applicant on…
Jennifer Whitty joined UEA in April 2016 as Professor of Health Economics. She leads the Health Economics Group and the Public Health and Health Services Research Theme at the Norwich Medical School. Her research focusses on evaluating patient-centred outcomes in health and healthcare to inform evidence-based decisions. Jennifer has particular interests in preference elicitation methods (including the Discrete Choice Experiment), and evaluating interventions related to pharmacy and medicines use, nursing, cardiovascular and respiratory conditions. She also undertakes economic evaluation alongside clinical trials. Jennifer collaborates with a number of researchers in these fields who are based in Europe and Australia, where…
Professor Ric Fordham is Professor in Public Health Economics at Norwich Medical School, University of East Anglia. He is also Director of Health Economics Consulting at UEA. Ric trained at York, Leeds, LSE, Western Australia and Cambridge universities and has worked extensively in Health Economics for over 25 years internationally as well as in the UK. His main interests are: Economics of public health; technology appraisal; innovation diffusion and ‘return on investment'; multi-criteria decision analysis (MCDA) and Programme Budgeting and Marginal Analysis (PBMA). He retains a strong research interest in the economics of bone and joint disease. Recent research has…
Lisa Irvine is a Research Fellow in the Health Economics Group at UEA. She has expertise in conducting economic evaluations alongside clinical trials, systematic reviews and meta-analyses, and population surveys, applied to a variety of conditions, primarily in public health, mental illness, and care for the elderly. As part of CLAHRC, her projects include an economic evaluation of the EQUIP trial, and comparison of health resource use measurement in clinical trials.
Christina-Jane graduated from the University of Southampton in 2013 with Biomedical Sciences (BSc) and has also gained her MSc in Health Economics at the University of East Anglia (UEA). After completion of her masters, she worked as a Research Associate at the UEA for a short time. She continues to study at the UEA and began her Health Economics PhD in January 2015 under the supervision of Professor Garry Barton, Professor Andrew Wilson, and Professor Tracey Sach. Her PhD is entitled: “Economics of asthma: estimating quality of life in people with asthma attacks”. This PhD has three main components where,…
Professor Tracey Sach has a chair in Health Economics and is a member of the Health Economics Group, Norwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia and her main area of expertise is in the methods and application of economic evaluation in health. Tracey has undertaken methodological work exploring how to measure costs and outcomes in economic evaluations. This has included work comparing methods for measuring productivity costs; research comparing two measures of utility (the EQ-5D and SF-6D); and projects testing the use of contingent valuation methods to estimate a monetary willingness to pay value.…